Calton & Associates, Inc. Exact Sciences Corp Transaction History

Calton & Associates, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$62.68 - $95.05 $162,215 - $245,989	2,588 New	2,588 $243,000
Q3 2021 Nov 05, 2021	SELL	$90.24 - $124.05 $169,651 - $233,214	-1,880 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$93.66 - $139.27 $936 - $1,392	-10 Reduced 0.53%	1,880 $234,000
Q1 2021 May 03, 2021	SELL	$116.57 - $155.01 $116 - $155	-1 Reduced 0.05%	1,890 $249,000
Q4 2020 Jan 25, 2021	SELL	$99.61 - $142.12 $68,133 - $97,210	-684 Reduced 26.56%	1,891 $251,000
Q3 2020 Oct 30, 2020	SELL	$72.92 - $102.01 $6,781 - $9,486	-93 Reduced 3.49%	2,575 $263,000
Q2 2020 Aug 10, 2020	BUY	$55.75 - $92.75 $148,741 - $247,457	2,668 New	2,668 $232,000
Q1 2020 Apr 30, 2020	SELL	$37.9 - $104.44 $103,467 - $285,121	-2,730 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$77.66 - $99.74 $2,407 - $3,091	31 Added 1.15%	2,730 $253,000
Q3 2019 Nov 07, 2019	BUY	$90.37 - $122.49 $243,908 - $330,600	2,699 New	2,699 $244,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.